The Role of Estrogen Receptor Alpha Variant Size and Localization in Modulating TLR7-Induced Inflammation
雌激素受体 α 变体大小和定位在调节 TLR7 诱导的炎症中的作用
基本信息
- 批准号:10571915
- 负责人:
- 金额:$ 39.66万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-02-14 至 2026-12-31
- 项目状态:未结题
- 来源:
- 关键词:AF2AddressAffectAgeAnti-Inflammatory AgentsAntigen-Antibody ComplexAntiinflammatory EffectAutoantibodiesAutoimmune DiseasesAutoimmunityB-LymphocytesBindingBiologicalBlood VesselsBone MarrowCell LineCell membraneCell physiologyCellsChromatinDNA BindingDataDendritic CellsDepositionDevelopmentDiseaseDoseEnd stage renal failureEndosomesEnvironmental ExposureEpidemiologyEstrogen Receptor alphaEstrogen ReceptorsEstrogensEventFemaleGenesGenetic TranscriptionGenomicsGoalsGonadal Steroid HormonesHumanImmuneImmune TargetingImmune responseIn VitroIncidenceInflammationInflammatoryInflammatory InfiltrateInflammatory ResponseInnate Immune ResponseInterferon Gamma Receptor Beta ChainInvestigationKidneyKidney DiseasesLengthLigand Binding DomainLocationLupusLupus NephritisMacrophageMediatingMembraneMusMutant Strains MiceNephritisNuclearPathway interactionsPatientsPeripheral Blood Mononuclear CellPredispositionPropertyProtein IsoformsProteinsProteinuriaPubertyRaceReportingResearchRisk FactorsRoleSamplingSelective Estrogen Receptor ModulatorsSerumSex BiasSex ChromosomesSignal TransductionStructureSystemic Lupus ErythematosusTLR7 geneTechnologyTestingTherapeuticTimeTissue-Specific Gene ExpressionTissuesToll-like receptorsTransactivationVariantWomanWorkX Inactivationcell typedifferential expressiondigitalexperimental studygenetic corepressorimmunoregulationin vivolupus prone micemalemonocytemutantnew therapeutic targetnext generationnon-genomicnovelnovel strategiesnovel therapeuticsoverexpressionprotective effectprototypereceptorreproductiveresponsesexsex disparitytooltranscription factor
项目摘要
Systemic lupus erythematosus (SLE) is one of many autoimmune diseases that disproportionately affects
females. Although many risk factors for lupus are identified: >170 genes including GPR174, myriad
environmental exposures, and aberrant X chromosome inactivation, none of these sufficiently explain the steep
rise in incidence of ADs at the time of puberty in a female-specific manner. Epidemiology suggests a major role
for sex hormones and their receptors in autoimmune diseases. We previously showed that female lupus-prone
mice, expressing only a short form of estrogen receptor alpha (ERα short), have significantly reduced renal
disease and increased survival. Determining the mechanism of this protective effect, which is estrogen
dependent, is the primary goal of this proposal. Of note, ERα-/- (null) lupus prone mice were not similarly
protected. Combined, our data suggest that the presence of the short form of ERα confers protection, not the
absence of full-length ERα. Others and we demonstrated a critical role for ERα in dendritic cell (DC) development
and endosomal Toll-like receptor (TLR) responsiveness. Interestingly, the ERα expressed in ERα short mice is
similar in structure to an endogenous ERα variant (ERα46) that lacks the same AF-1 domain, and differentially
regulates gene transcription compared to full length ERα. Overexpressing ERα46 in vitro also modulates TLR-
induced responses, relevant to this proposal. In the proposed study, we will further investigate the role of ERα
short variants in modulating TLR7-induced immune responses, and determine whether genomic and/or non-
genomic mechanisms of ERα short variant action are protective. Our overall hypothesis is that increasing
expression of ERα short or ERα46 in immune cells will be anti-inflammatory, and that the ratio of ERα46
to ERα66 is decreased in lupus patients versus healthy controls. We also hypothesize that targeting
immune cells with novel anti-inflammatory selective estrogen receptor modulators (SERMs) that alter ERα
membrane signaling and/or ERα-induced transcription will uncouple estrogen-mediated anti-inflammatory
responses from those impacting reproductive tissues. We will test our hypotheses by accomplishing these
Specific Aims: 1) Overexpress ERα short or treat immune cells with novel SERMs (OBHS, PaPE) that select for
anti-inflammatory properties of ERα and determine the effect on known TLR7-induced inflammatory endpoints,
2) Investigate effects of membrane-only ERα signaling vs. nuclear only ERα expression on TLR7-induced
pathways in mice, and 3) Identify ERα variants in human monocyte-derived dendritic cells (mo-DCs) and B cells
using droplet digital PCR and Iso-Seq technology, to determine whether ERα46 is differentially expressed in
lupus patients vs. controls, potentially explaining a biologic difference in females predisposed to autoimmunity.
These aims will allow us to determine if we can separate ERα's reproductive effects from its potentially modifiable
immune effects as a therapeutic strategy, which if successful, will provide novel approaches to immune
modulation in lupus and other immune mediated diseases, especially those with a significant sex bias.
系统性红斑狼疮 (SLE) 是多种自身免疫性疾病之一,对患者的影响尤为严重
虽然狼疮的许多危险因素已被确定:> 170 个基因,包括 GPR174、无数。
环境暴露和异常 X 染色体失活,这些都不足以解释陡峭的
流行病学表明青春期 AD 发病率的上升具有重要作用。
对于性激素及其受体在自身免疫性疾病中的作用,我们之前表明女性易患狼疮。
仅表达短形式雌激素受体α(ERα短)的小鼠,肾功能显着降低
确定这种保护作用的机制,即雌激素。
值得注意的是,ERα-/-(无效)狼疮易感小鼠的情况并不相似。
综合起来,我们的数据表明,ERα 的缩写形式的存在提供了保护,而不是 ERα。
缺乏全长 ERα。其他人和我们证明了 ERα 在树突状细胞 (DC) 发育中的关键作用。
和内体 Toll 样受体 (TLR) 反应性提示,ERα 短小鼠中表达的 ERα 是
结构与缺乏相同 AF-1 结构域的内源 ERα 变体 (ERα46) 相似,并且不同
与全长 ERα 相比,其可调节基因转录 体外过表达 ERα46 还可调节 TLR-。
与本提案相关的诱导反应在拟议的研究中,我们将进一步研究 ERα 的作用。
调节 TLR7 诱导的免疫反应的短变异,并确定基因组和/或非
ERα 短变异作用的基因组机制是保护性的。
免疫细胞中表达ERα短或ERα46就会有抗炎作用,而且ERα46的比例
与健康对照组相比,狼疮患者的 ERα66 减少。
具有改变 ERα 的新型抗炎选择性雌激素受体调节剂 (SERM) 的免疫细胞
膜信号传导和/或 ERα 诱导的转录将解开雌激素介导的抗炎作用
我们将通过完成这些来检验我们的假设。
具体目标: 1) 过度表达 ERα 或用新型 SERM(OBHS、PaPE)治疗免疫细胞,这些 SERM 会选择
ERα 的抗炎特性并确定对已知 TLR7 诱导的炎症终点的影响,
2) 研究仅膜 ERα 信号传导与仅细胞核 ERα 表达对 TLR7 诱导的影响
小鼠体内的通路,以及 3) 识别人单核细胞衍生的树突状细胞 (mo-DC) 和 B 细胞中的 ERα 变体
利用液滴数字PCR和Iso-Seq技术,确定ERα46在
狼疮患者与对照组的比较,可能解释了易患自身免疫的女性的生物学差异。
这些目标将使我们能够确定是否可以将 ERα 的生殖影响与其潜在的可改变性区分开来。
免疫效应作为一种治疗策略,如果成功,将为免疫提供新的方法
狼疮和其他免疫介导疾病的调节,特别是那些具有显着性别偏见的疾病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Melissa A Cunningham其他文献
Melissa A Cunningham的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Melissa A Cunningham', 18)}}的其他基金
The Role of Estrogen Receptor Alpha Variant Size and Localization in Modulating TLR7-Induced Inflammation
雌激素受体 α 变体大小和定位在调节 TLR7 诱导的炎症中的作用
- 批准号:
10365365 - 财政年份:2022
- 资助金额:
$ 39.66万 - 项目类别:
Molecular mechanisms of estrogen receptor alpha modulating the inflammatory response in systematic lupus erythematosus
雌激素受体α调节系统性红斑狼疮炎症反应的分子机制
- 批准号:
9254202 - 财政年份:2016
- 资助金额:
$ 39.66万 - 项目类别:
Molecular mechanisms of estrogen receptor alpha modulating the inflammatory response in systematic lupus erythematosus
雌激素受体α调节系统性红斑狼疮炎症反应的分子机制
- 批准号:
9115454 - 财政年份:2016
- 资助金额:
$ 39.66万 - 项目类别:
Molecular mechanisms of estrogen receptor alpha modulating the inflammatory response in systematic lupus erythematosus
雌激素受体α调节系统性红斑狼疮炎症反应的分子机制
- 批准号:
9901448 - 财政年份:2016
- 资助金额:
$ 39.66万 - 项目类别:
相似国自然基金
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
相似海外基金
The Role of Estrogen Receptor Alpha Variant Size and Localization in Modulating TLR7-Induced Inflammation
雌激素受体 α 变体大小和定位在调节 TLR7 诱导的炎症中的作用
- 批准号:
10365365 - 财政年份:2022
- 资助金额:
$ 39.66万 - 项目类别:
Targeting Vascular Leak and Intercalated Disk Nanodomains to Prevent Atrial Fibrillation
靶向血管渗漏和闰盘纳米结构域以预防心房颤动
- 批准号:
10449096 - 财政年份:2020
- 资助金额:
$ 39.66万 - 项目类别:
Targeting Vascular Leak and Intercalated Disk Nanodomains to Prevent Atrial Fibrillation
靶向血管渗漏和闰盘纳米结构域以预防心房颤动
- 批准号:
10652380 - 财政年份:2020
- 资助金额:
$ 39.66万 - 项目类别:
Targeting Vascular Leak and Intercalated Disk Nanodomains to Prevent Atrial Fibrillation
靶向血管渗漏和闰盘纳米结构域以预防心房颤动
- 批准号:
10171612 - 财政年份:2020
- 资助金额:
$ 39.66万 - 项目类别:
Molecular mechanisms of estrogen receptor alpha modulating the inflammatory response in systematic lupus erythematosus
雌激素受体α调节系统性红斑狼疮炎症反应的分子机制
- 批准号:
9254202 - 财政年份:2016
- 资助金额:
$ 39.66万 - 项目类别: